From Research to Revenue: Managing the Pharmaceutical Transition

Red Travelers Umbrella.
By Travelers
5 minutes

In the Know with Jennifer Ampulski - Life Sciences Practice Lead, Travelers

While bringing a new drug to market is exciting, it is also a journey paved with potential risks. As you scale into production, consider off-label use and navigate the potential perils of artificial intelligence, the exposures add up.

Jennifer Ampulski, Travelers Life Sciences Practice Lead, is a life sciences industry expert with invaluable experience to share. Hear firsthand in her In the Know series, the challenges she’s seen pharma businesses face as they transition from clinical trials to commercialization.

Episode 1: Scaling Manufacturing

Patient injury, shipment issues, workers compensation, drug contamination — discover some of the liabilities you may encounter as you journey from FDA approval to market.

Episode 2: Off-Label Concerns

If doctors prescribe your drug for conditions you didn’t anticipate, then what? Jennifer explains how you can help protect your business from some of the common risks of off-label use.  

Episode 3: The Risks of AI

Cyberattacks could corrupt data or create false information. Learn how to navigate the potential impacts of artificial intelligence on pharmaceutical commercialization.

3 scientists conducting experiments in a pharmaceutical lab

Expanding Risks for Pharmaceutical Companies

Download our whitepaper to learn about the expanding risk landscape for emerging pharmaceutical companies and tips to help keep yours on track.

Doctor using medical IoT to see patient X-rays.

Top Stories

The Risks of IoT in Medicine and Healthcare

From the smallest sensors to entire operating room systems, the Internet of Things (IoT) is helping to save lives and changing the practice of medicine.

Related Products & Services

Life science companies face unique risks every day. Learn how life science insurance from Travelers can help protect your business.

Policies that fit your unique responsibilities and exposures – whether your business is a private, public, nonprofit or financial institution.

More Prepare & Prevent

How Tech and Life Sciences Companies Can Capitalize on the AI Revolution and Manage the Risks

Reap the benefits while managing the risk of artificial intelligence. Learn how to mitigate risk while opening the door to pursue new opportunities with AI.

Two employees watching at the monitor.

More Prepare & Prevent

Managing Cyber Risk for Life Sciences Companies

Life sciences companies are a growing target for cybercriminals. Learn how to prevent an attack and protect your interests.

scientist in scrubs tending to a screen.

More Prepare & Prevent

The Future of Semiconductors Promises to Be a Period of Growth, Risk and Opportunity

Future semiconductor technologies promise more powerful, efficient and innovative processors and devices but also introduce new challenges and risks.

Red webinar background with the words "Decoding the Future of Semiconductors: Emerging Trends, Risks, and Opportunities" on it.